Actionable Options for Wednesday, August, 24
Options with increasing call volume and volatility movement: ULTA SBUX ADSK
Options with increasing put volume and volatility movement: HLF SPLK HPQ
Sarepta Therapeutics (SRPT) volatility at five-week lows as shares rally into FDA decision on eteplirsen. Current 30-day call option implied volatility is at 210, compared to a one- month ago level of 280.
Medivation (MDVN) volatility has collapsed after recently announcing Pfizer (PFE) acquiring. Current 30-day call option implied volatility is at 12, compared to a one- month ago level of 31.
Clovis (CLVS) up 4.5% after the FDA accepts the company's New Drug Application for Rucaparib for priority review. Current 30-day call option implied volatility is at 95, compared to a one- month ago level of 82.
Back to All News articles